Cargando…
Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule
The application of Trastuzumab on gastric cancer patients is based on Her2/neu immunostaining. The testing method relies on visual estimation of both membranous staining intensity, and positive tumor ratio with respect to a 10% cutoff. We evaluated the effect of inter- and intraobserver variations o...
Autores principales: | Behrens, Hans-Michael, Warneke, Viktoria S, Böger, Christine, Garbrecht, Nele, Jüttner, Eva, Klapper, Wolfram, Mathiak, Micaela, Oschlies, Ilske, Rudolph, Ursula, Stuhlmann-Laeisz, Christiane, Trick, David, Röcken, Christoph, Hufnagl, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329007/ https://www.ncbi.nlm.nih.gov/pubmed/25515030 http://dx.doi.org/10.1002/cam4.365 |
Ejemplares similares
-
Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014) -
Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization
por: Mathiak, Micaela, et al.
Publicado: (2017) -
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
por: Warneke, V. S., et al.
Publicado: (2013) -
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
por: Böger, Christine, et al.
Publicado: (2016) -
The Spatial Distribution of LGR5(+) Cells Correlates With Gastric Cancer Progression
por: Simon, Eva, et al.
Publicado: (2012)